MaxCyte, Inc. (MXCT)

NASDAQ

$1.24

$+0.30

(+30.66%)

Regular Market

MaxCyte, Inc. (MXCT) Live Price Chart

Last updated: ⁦2026-10-14 15:30:01⁩. Prices reflect the latest regular market data. Stock price data is sourced from Massive.

Summary

MaxCyte, Inc. (MXCT) operates in the SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH sector and is listed on NASDAQ. The stock is currently priced at $1.24, with a market capitalization of $102.69M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.64 to $1.87. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$102.69M
Open	$1.23
Day's High	$17.44
Day's Low	$0.64
Previous Close	$0.96
Volume	9.35M
Average Volume	592.39K
P/E Ratio	--
52-Week High	$1.87
52-Week Low	$0.64
Dividend Yield	--
Earnings Date	--

MaxCyte, Inc. (MXCT) Stock Price Today

MaxCyte, Inc. (MXCT) is currently trading at $1.24 as of 2026-10-14 15:29:00, up 28.07% ($0.27) from the previous close of $0.96

During today's regular trading session, MXCT has traded between $0.64 and $17.44, with a trading volume of 9.35M shares. The current price is near the lower end of today's range.

MaxCyte, Inc. (MXCT) 7-Day Stock Price Change

Over the past seven days, MaxCyte, Inc. (MXCT) moved from $1.08 to $1.24, representing a gain of 14.35% ($0.16).

The stock traded between $0.94 and $1.32 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.

The average daily volume was 290.68 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

MXCT 52-Week Price Position

Position in Range: 48.4%

52W Low$0.64

52W High$1.87

MXCT is currently trading at $1.24, placing it 48.4% of the way from its 52-week low of $0.64 to its 52-week high of $1.87. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is MaxCyte, Inc. (MXCT)?

MaxCyte Inc is a life sciences company focused on advancing the discovery, development, and commercialization of next-generation cell therapies. It uses its proprietary cell engineering technology platform to support biotechnology and pharmaceutical customers in cell therapy, gene editing, immuno-oncology, and biologic development. It operates in one segment: cell engineering technology, which generates revenue mainly from product sales, licenses, research and clinical license fees, and program-related revenues as its SPL customers achieve development and regulatory milestones. Its platform, the ExPERT Platform, is based on Flow Electroporation technology designed to efficiently and safely modify human cells with high efficiency, low cytotoxicity, and scalability for clinical use.

MaxCyte, Inc. Information

Industry	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Employees	91
Exchange	NASDAQ
Company Website	https://www.maxcyte.com

How to Buy MaxCyte, Inc. (MXCT) Stock on MEXC

Eligible investors can buy real shares of MaxCyte, Inc. (MXCT) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for MXCT and Place Your Order

Open the RealStocks trading page and search for MXCT. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is MaxCyte, Inc. (MXCT) stock price today?

MaxCyte, Inc. (MXCT) is currently trading at $ 1.24, up 28.07% ($0.27) from the previous close of $ 0.96. Intraday prices update in real time during regular trading hours.

2.Is MXCT stock going up or down today?

As of 2026-10-14 15:29:00, MXCT is trading at $ 1.24, up 28.07% ($0.27) from its previous close of $ 0.96. The stock has traded between $ 0.64 and $ 17.44 during today’s regular session. Past price movements do not guarantee future results.

3.What is MXCT pre-market price?

As of 2026-10-14 15:29:00, MXCT is trading at $ 1.19 in pre-market trading, up 23.09% ($0.22) from the previous close of $ 0.96. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is MXCT after-hours price?

As of 2026-10-14 15:29:00, MXCT is trading at $ 1.00 in after-hours trading, up 3.18% ($0.03) from the regular-session close of $ 0.96. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is MXCT stock trading now?

MXCT trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does MXCT sit relative to its 52-week high and low?

Over the past 52 weeks, MXCT has traded between a low of $ 0.64 and a high of $ 1.87. At $ 1.24, the stock is positioned 48.4% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is MaxCyte, Inc. in?

MaxCyte, Inc. (MXCT) operates in the SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is MaxCyte, Inc.'s market capitalization and where is it listed?

MaxCyte, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 102.69M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is MXCT valued in terms of P/E ratio and EPS?

MXCT trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0.35. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does MaxCyte, Inc. pay a dividend?

MaxCyte, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.